feedback
facebook page
Follow Me on Pinterest
twitter page
google plus page
rss feed

Recalled Product

Item detail and remedy information

Search Recalls or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Home > Recalled Products > Drugs > Lack of Proper Labeling > Endo Pharmaceuticals Inc. Robaxin (methocarbamol Tablets, USP) 750mg Tablets

Recall: Endo Pharmaceuticals Inc. Robaxin (methocarbamol Tablets, USP) 750mg Tablets

email
email

On 2018-09-28, the FDA announced that Endo Pharmaceuticals is conducting a recall on Robaxin (methocarbamol Tablets, USP) 750mg Tablets due to a possible lack of proper labeling. The recalled products were sold under the brand name(s) Endo Pharmaceuticals Inc. during an unspecified time period throughout the regions shown in the map below.

In recent months, there have been 3 drugs recalls due to potential lack of proper labeling, including montelukast sodium tablets, usp 10mg, children's advil suspension bubble gum flavored 4 fl oz bottle and more. Additionally, there have been 27 drug and medical device recalls due to other health hazards as well as 63 food recalls.

Email Me About Recalls On:
Food  |  Drugs  |  Medical Devices  |  Pet Care Products  |  All of These


Robaxin (methocarbamol Tablets, USP) 750mg Tablets, 100 Count Bottle pack
Note: Images may not be available for every version. Please review the detailed description below.

Company Contact Information:

Name: Endo Pharmaceuticals
Website: www.inmar.com
Phone: 1-866-391-0620

Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.

Detailed Recall Information



Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.

Product Description: Robaxin (methocarbamol tablets, USP) 750mg Tablets

Brand Name(s): Endo Pharmaceuticals Inc.

Reason for Recall: Due to Incorrect Daily Dosing Information on Label

Official Recall Date: 2018-09-28


Advertisement

Additional information provided by the FDA.gov:

Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc., is voluntarily recalling two lots of Robaxin (methocarbamol tablets, USP) 750mg Tablets 100 Count Bottle pack to the consumer level. The products have been found to have incorrect daily dosing information on the label due to a labeling error which misstates the daily dose as "two to four tablets four times daily" rather than the correct dosage of "two tablets three times daily." (see picture below for location of incorrect text). Read More.


More information may be available at FDA.gov
Advertisement


Latest Safety Recalls

Select image for details, including additional styles.

 

Advertisement

Comments

Do you have comments or questions about this recall? Share them here.
Note: The recalling companies may not be monitoring these comments; they should be directed toward the public. Community Guidelines apply.
comments powered by Disqus
Back to Top



Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.

Search Recalled Products or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Latest Product Recalls
Consumers
Register Products
Check for Recalls
Find Resources
Brands & Retailers
Connect to Customers

Consignment Sales
Check Inventory
Install Recall Finder
Take Safety Pledge

Home Inspectors
Check Appliances
Developers
APIs & Feeds
Recall Search for Web
Recall Search for Mobile
Facebook Apps

Researchers
Product Recall Statistics
About
Company
Contact
Press
Blog

Social
Facebook
Twitter